Robert Hevner

NPI: 1821174624
Total Payments
$4,043
2021 Payments
$855.99
Companies
2
Transactions
12

Payment Breakdown by Category

Education$2,897 (71.7%)
Other$1,146 (28.3%)

Payments by Nature

Nature of Payment Amount Transactions Share
Education $2,897 11 71.7%
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $1,146 1 28.3%

Top Paying Companies

Company Total Records Latest Year
Novartis Gene Therapies, Inc. (fka AveXis, Inc.) $2,897 11 $0 (2021)
AveXis $1,146 1 $0 (2019)

Payment History by Year

Year Amount Transactions Top Company
2021 $855.99 2 Novartis Gene Therapies, Inc. (fka AveXis, Inc.) ($855.99)
2020 $2,041 9 Novartis Gene Therapies, Inc. (fka AveXis, Inc.) ($2,041)
2019 $1,146 1 AveXis ($1,146)

All Payment Transactions

12 individual payment records from CMS Open Payments

Date Company Product Nature Form Amount Type
07/19/2021 Novartis Gene Therapies, Inc. (fka AveXis, Inc.) ZOLGENSMA (Biological) Education In-kind items and services $168.88 General
Category: GENE THERAPY
06/04/2021 Novartis Gene Therapies, Inc. (fka AveXis, Inc.) ZOLGENSMA (Biological) Education In-kind items and services $687.11 General
Category: GENE THERAPY
12/15/2020 Novartis Gene Therapies, Inc. (fka AveXis, Inc.) ZOLGENSMA (Biological) Education In-kind items and services $55.75 General
Category: GENE THERAPY
06/01/2020 Novartis Gene Therapies, Inc. (fka AveXis, Inc.) ZOLGENSMA (Biological) Education In-kind items and services $494.76 General
Category: GENE THERAPY
06/01/2020 Novartis Gene Therapies, Inc. (fka AveXis, Inc.) ZOLGENSMA (Biological) Education In-kind items and services $300.67 General
Category: GENE THERAPY
02/18/2020 Novartis Gene Therapies, Inc. (fka AveXis, Inc.) ZOLGENSMA (Biological) Education In-kind items and services $215.95 General
Category: GENE THERAPY
02/18/2020 Novartis Gene Therapies, Inc. (fka AveXis, Inc.) ZOLGENSMA (Biological) Education In-kind items and services $157.27 General
Category: GENE THERAPY
02/18/2020 Novartis Gene Therapies, Inc. (fka AveXis, Inc.) ZOLGENSMA (Biological) Education In-kind items and services $157.27 General
Category: GENE THERAPY
02/18/2020 Novartis Gene Therapies, Inc. (fka AveXis, Inc.) ZOLGENSMA (Biological) Education In-kind items and services $90.91 General
Category: GENE THERAPY
01/15/2020 Novartis Gene Therapies, Inc. (fka AveXis, Inc.) ZOLGENSMA (Biological) Education In-kind items and services $290.95 General
Category: GENE THERAPY
01/14/2020 Novartis Gene Therapies, Inc. (fka AveXis, Inc.) ZOLGENSMA (Biological) Education In-kind items and services $277.73 General
Category: GENE THERAPY
10/04/2019 AveXis ZOLGENSMA (Biological) Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Cash or cash equivalent $1,146.05 General
Category: GENE THERAPY

About Robert Hevner

Robert Hevner is a Anatomic Pathology & Clinical Pathology healthcare provider based in San Diego, California. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 10/27/2006. The National Provider Identifier (NPI) number assigned to this provider is 1821174624.

According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Robert Hevner has received a total of $4,043 in payments from pharmaceutical and medical device companies, with $855.99 received in 2021. These payments were reported across 12 transactions from 2 companies. The most common payment nature is "Education" ($2,897).

Practice Information

Products in Payments

  • ZOLGENSMA (Biological) $4,043

Data Sources

Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.

Anatomic Pathology & Clinical Pathology Doctors in San Diego